Correlation of prostate volume with severity of lower urinary tract symptoms as measured by international prostate symptoms score and maximum urine flow rate among patients with benign prostatic hyperplasia

Awaisu, Mudi; Mashaly, Ahmed; Lawal, Ahmad Tijjani; Sudi, Abdullahi; Tolani, Musliu Adetola; Oyelowo, Nasir; Muhammad, Muhammad Salihu; Bello, Ahmad; Maitama, Hussaini Yusuf

doi:10.1186/s12301-021-00122-4

Cited by 11 publications

(18 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…6 There was no correlation between the prostate volume and IPSS scores unlike this study in Africans. 5 In a study by Azhar et al, there was a statistically significant difference between the grading of prostate by trans abdominal ultrasound and IPSS scores similar to the results of this study. 7 A study by Awaisu et al had shown a positive and significant correlation of between the prostate volume and IPSS scores.…”

Section: Disussionsupporting

confidence: 90%

“…3 A study by Awaisu et al had noted that, the mean age of the patients was 64.22 years. 5 Increased frequency was the main lower urinary tract symptom in this study followed by urgency, incomplete emptying, nocturia, poor streaming and straining.…”

Section: Disussionmentioning

confidence: 52%

“…7 A study by Awaisu et al had shown a positive and significant correlation of between the prostate volume and IPSS scores. 5 These findings suggested that, the transabdominal ultrasound being a noninvasive procedure have a significant correlation of prostatic volume with the IPSS scores. Hence, the transabdominal ultrasound can be widely used than the invasive diagnostic procedures like trans rectal ultrasound.…”

Section: Disussionmentioning

confidence: 86%

“…A study by Awaisu et al had shown that, majority of the patients were unhappy about their symptoms. 5 The quality of life usually deteriorates with deterioration of the prostatic enlargement due to clinical symptoms hampering the day today clinical symptoms.…”

Section: Disussionmentioning

confidence: 99%

See 3 more Smart Citations

Clinical relevance of prostatic enlargement on transabdominal ultrasound

Ahlawat

Mahale

2022

ijhs

View full text Add to dashboard Cite

Background: The prostate enlargement is an important public health problem in the geriatric male patients. The diagnostic procedures of BPH ranges from non-invasive to invasive procedures. This study was undertaken to study the correlation of findings of transabdominal ultrasound with the IPSS scores and QOL scores.Material and methods: A cross sectional study was conducted in the department of radiology on 100 patients attending urology OPD and IPD in a tertiary care hospital in Mangalore. The transabdominal ultrasonography was conducted by an expert sonologist and prostate volume was measured. The data was collected by using a pre-designed proforma and the results were tabulated. Results: Majority of the patients in this study were aged between 60 – 65 years. Increased frequency was most common lower urinary tract symptom observed in this study. There was a statistically significant difference in the grading of prostatic enlargement and IPSS scores. There was no significant difference of grading of prostate volume and Quality of Life scores. Conclusion: This study had shown that, transabdominal ultrasound assessed prostate volume correlates with the IPSS scores.

show abstract

Section: Disussionsupporting

confidence: 90%

Section: Disussionmentioning

confidence: 52%

Section: Disussionmentioning

confidence: 86%

Section: Disussionmentioning

confidence: 99%

See 2 more Smart Citations

Clinical relevance of prostatic enlargement on transabdominal ultrasound

Ahlawat

Mahale

2022

ijhs

View full text Add to dashboard Cite

show abstract

“…Earlier studies on this topic have demonstrated variable results. [32][33][34][35][36][37][38] Additional research in this area is needed to determine if certain clinical or patient characteristics may in uence the relationship between PV and IPSS.…”

Section: Discussionmentioning

confidence: 99%

Change in prostate volume reduction and symptomatic improvement in men treated with Rezūm convective water vapour thermal thera

Bhojani

Vannabouathong²,

Chughtai

et al. 2022

Preprint

View full text Add to dashboard Cite

Background: Rezūm convective water vapour thermal therapy is a minimally invasive, office-based treatment for benign prostatic hyperplasia (BPH). While studies have demonstrated its efficacy in symptomatic improvement, its effect on objective measures such as prostate volume (PV) reduction is poorly characterized. The purpose of this study was to evaluate the change in PV and its relationship to improvement in symptom scores following Rezūm therapy. Methods: Quality of life outcomes and PV were assessed at baseline and 12 months post-procedure. The percent change from baseline in outcomes and PV were calculated for each patient, as was the injection to baseline volume ratio. The association between the total number of vapour injections and changes in outcomes and PV were evaluated using linear regression models. Results: A total of 49 patients (mean age = 67.8; standard deviation [SD] = 9.4) underwent the procedure between April 2019 and September 2020, with a median baseline PV of 71.5 and median number of vapour injections of 11.0. At 12 months, the median percent change in prostate volume was -34.0% (interquartile range: -49.2%, -16.7%), with 45/49 (91.8%) patients having reduced volume. Among the 45 patients with reduced volume at 12 months, every 10% increase in volume reduction was associated with a 7.5% (95% confidence interval, 1.4% to 13.6%; p=0.02) improvement in the International Prostate Symptom Score. There was no significant association between the total number of injections or injection to baseline volume ratio and change in PV. Conclusions: In this cohort of patients treated with Rezūm convective water vapour thermal therapy for BPH, it was demonstrated that there is a correlation between greater PV reduction and greater symptomatic improvement. Additionally, this study showed no association between more injections or the ratio of injections to prostate volume changes, refuting the claim that more injections are better.

show abstract

One‐year outcomes after prostate artery embolization versus laser enucleation: A network meta‐analysis

Bhatia,

Porto,

Maini

et al. 2023

BJUI Compass

View full text Add to dashboard Cite

BackgroundAlthough holmium laser enucleation (HoLEP) is considered a size‐independent procedure for treatment of an enlarged prostate, prostate artery embolization (PAE) is emerging as an alternative modality to treat moderate and large benign prostatic hyperplasia. This study aims to compare the early post‐operative and short‐term efficacy of PAE and HoLEP.MethodsPubMed, Cochrane Library and EMBASE databases were searched. Network meta‐analysis was performed following PRISMA‐N‐guidelines. Post‐operative parameters analysed include international prostate symptom score (IPSS), quality of life (QOL), post‐void residual urine (PVR), maximal uroflow rate (Qmax) and serious adverse events (SAE). Random effects model calculated weighted mean differences (WMD). If 95%CI crossed the line of no effect (WMD = 0), evidence indicated no statistically significant difference between treatments compared.ResultsQualitative and quantitative syntheses included 20 and 18 studies with 1991 and 1606 patients, respectively. At 3 months, there was no statistically significant difference between PAE and HoLEP in IPSS score improvement [WMD: −2.21: 95%CI: (−10.20, 5.78), favouring PAE], QoL score improvement [WMD: −0.22:95%CI: (−1.75, 1.32), favouring PAE] and PVR improvement [WMD: 26.97: 95%CI: (−59.53, 113.48), favouring HoLEP]. However, PAE was found inferior to HoLEP for Qmax improvement [WMD: 8.47, 95%CI: (2.89, 14.05), favouring HoLEP]. At 1‐year follow‐up, there was no statistically significant was found between PAE and HoLEP for IPSS score improvement [WMD:6.03, 95%CI: (−1.30, 13.35)], QoL score improvement [WMD: 0.03, 95%CI: (−1.19, 1.25)], PVR improvement [WMD:4.11, 95%CI: (−32.31, 40.53)] and Qmax improvement [WMD:2.60, 95%CI: (−2.20, 7.41)] with all differences favouring HoLEP. PAE was superior to HoLEP for SAE [PAE vs. HoLEP‐OR: 0.68, 95%CI: (0.25, 1.37)].ConclusionHoLEP was superior to PAE at 3 months for Qmax improvement. There was no significant difference in IPSS, QoL, PVR and Qmax improvement at 1 year between PAE and HoLEP. PAE was also associated with lesser SAE compared to HoLEP. Studies on the long‐term outcome of PAE are needed to establish the durability of early outcomes after PAE.

show abstract

Correlation of prostate volume with severity of lower urinary tract symptoms as measured by international prostate symptoms score and maximum urine flow rate among patients with benign prostatic hyperplasia

Cited by 11 publications

References 23 publications

Clinical relevance of prostatic enlargement on transabdominal ultrasound

Clinical relevance of prostatic enlargement on transabdominal ultrasound

Change in prostate volume reduction and symptomatic improvement in men treated with Rezūm convective water vapour thermal thera

One‐year outcomes after prostate artery embolization versus laser enucleation: A network meta‐analysis

Contact Info

Product

Resources

About